Showing results (531-540 of 636) with videos related to

Sort By:
Pageof 64
Theranostics|June 20, 2013
Biologically-targeted detection of primary and micro-metastatic ovarian cancerTracy W Liu, Jocelyn M Stewart, Thomas D Macdonald, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 25, 2000
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningU Menon, A Talaat, A N Rosenthal, et al.
Archives of Environmental Contamination and Toxicology|July 13, 2002
An assessment of injury to sediments and sediment-dwelling organisms in the Grand Calumet River and Indiana Harbor Area of Concern, USAD D MacDonald, C G Ingersoll, D E Smorong, et al.
NPJ Vaccines|February 19, 2019
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challengeGenevieve M Weir, Lisa D MacDonald, Rajkannan Rajagopalan, et al.
Bone Marrow Transplantation|May 1, 1993
Immunotherapy with interleukin 2 after ABMT in AMLM D Hamon, H G Prentice, D J Gottlieb, et al.
British Journal of Haematology|June 1, 1990
Thrombocytopenia after bone marrow transplantation for leukaemia: changes in megakaryocyte growth and growth-promoting activityJ A Adams, A A Gordon, Y Z Jiang, et al.
Annals of Surgery|August 14, 2014
Increased trauma center volume is associated with improved survival after severe injury: results of a Resuscitation Outcomes Consortium studyJoseph P Minei, Timothy C Fabian, Danielle M Guffey, et al.
Waste Management (New York, N.Y.)|September 22, 2017
Greenhouse gas and ammonia emissions from production of compost bedding on a dairy farmM A Fillingham, A C VanderZaag, S Burtt, et al.
Journal of Medicinal Chemistry|April 15, 1994
Thiopyrano[2,3,4-cd]indoles as 5-lipoxygenase inhibitors: synthesis, biological profile, and resolution of 2-[2-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5 -dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic acidJ H Hutchinson, D Riendeau, C Brideau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responsesMohan Karkada, Genevieve M Weir, Tara Quinton, et al.
Pageof 64